HomeCompareQRON vs MRK

QRON vs MRK: Dividend Comparison 2026

QRON yields 18018.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QRON wins by $18633001307266260992.00M in total portfolio value
10 years
QRON
QRON
● Live price
18018.02%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18633001307266260992.00M
Annual income
$18,431,768,966,926,280,000,000,000.00
Full QRON calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — QRON vs MRK

📍 QRON pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQRONMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QRON + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QRON pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QRON
Annual income on $10K today (after 15% tax)
$1,531,531.53/yr
After 10yr DRIP, annual income (after tax)
$15,667,003,621,887,337,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, QRON beats the other by $15,667,003,621,887,337,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QRON + MRK for your $10,000?

QRON: 50%MRK: 50%
100% MRK50/50100% QRON
Portfolio after 10yr
$9316500653633130496.00M
Annual income
$9,215,884,483,463,140,000,000,000.00/yr
Blended yield
98.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QRON
No analyst data
Altman Z
-23136.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QRON buys
0
MRK buys
0
No recent congressional trades found for QRON or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQRONMRK
Forward yield18018.02%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$18633001307266260992.00M$56.8K
Annual income after 10y$18,431,768,966,926,280,000,000,000.00$9,798.13
Total dividends collected$18619711198521020416.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QRON vs MRK ($10,000, DRIP)

YearQRON PortfolioQRON Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,812,502$1,801,801.80$11,206$366.19+$1.80MQRON
2$307,151,434$305,212,057.22$12,650$502.35+$307.14MQRON
3$48,667,022,851$48,338,370,816.14$14,407$694.19+$48667.01MQRON
4$7,210,053,431,136$7,157,979,716,686.14$16,585$967.82+$7210053.41MQRON
5$998,798,584,418,300$991,083,827,246,983.60$19,342$1,363.89+$998798584.40MQRON
6$129,380,351,742,642,780$128,311,637,257,315,230.00$22,913$1,947.19+$129380351742.62MQRON
7$15,672,057,030,122,314,000$15,533,620,053,757,686,000.00$27,662$2,823.89+$15672057030122.29MQRON
8$1,775,286,122,699,574,700,000$1,758,517,021,677,343,500,000.00$34,159$4,173.35+$1775286122699574.75MQRON
9$188,067,607,794,372,840,000,000$186,168,051,643,084,300,000,000.00$43,337$6,308.80+$188067607794372832.00MQRON
10$18,633,001,307,266,260,000,000,000$18,431,768,966,926,280,000,000,000.00$56,776$9,798.13+$18633001307266260992.00MQRON

QRON vs MRK: Complete Analysis 2026

QRONStock

Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.

Full QRON Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this QRON vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QRON vs SCHDQRON vs JEPIQRON vs OQRON vs KOQRON vs MAINQRON vs JNJQRON vs ABBVQRON vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.